Location History:
- San Diego, CA (US) (2007)
- San Francisco, CA (US) (2011)
Company Filing History:
2 out of 174 
1 out of 263 Years Active: 2007-2011
Title: Yi Li: Innovator in Pharmaceutical Chemistry
Introduction
Yi Li is a prominent inventor based in San Francisco, CA, known for his contributions to pharmaceutical chemistry. He holds 2 patents that focus on innovative compounds and their applications in treating serious medical conditions, including cancer.
Latest Patents
One of Yi Li's latest patents involves salts and polymorphs of a VEGF-R inhibitor. This invention relates to salts and free base forms of N,2-dimethyl-6-[7-(2-morpholinoethoxy)quinolin-4-yloxy]benzofuran-3-carboxamide. The invention further includes pharmaceutical compositions of these salts and free base forms, along with methods for treating disorders such as cancer using these compositions. Another significant patent pertains to polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-ce]indol-6-one. This invention focuses on novel polymorphic and amorphous forms and the processes for their preparation, which may be utilized in pharmaceutical compositions to treat diseases mediated by poly(ADP-ribose) polymerase activity, including cancer.
Career Highlights
Throughout his career, Yi Li has worked with notable companies such as Agouron Pharmaceuticals, Inc. and Cancer Research Technology Limited. His work has significantly impacted the field of pharmaceutical development, particularly in creating effective treatments for complex diseases.
Collaborations
Yi Li has collaborated with esteemed colleagues, including Jia Liu and Naresh Nayyar, contributing to advancements in pharmaceutical research and development.
Conclusion
Yi Li's innovative work in pharmaceutical chemistry and his patents reflect his commitment to improving treatment options for serious health conditions. His contributions continue to influence the field and inspire future research.